Iwona Kobielusz-Gembala

Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study.

A. Gasbarrini, B. Sands, I. Lawrance, 2023, Gastroenterology.